BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23207233)

  • 1. [Association of the xeroderma pigmentosum group D DNA repair gene with hepatocellular carcinoma].
    Zhang JJ; Ma JZ
    Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):683-7. PubMed ID: 23207233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma risk: a systematic review and meta-analysis.
    Peng Q; Li S; Lao X; Chen Z; Li R; Qin X
    Medicine (Baltimore); 2014 Dec; 93(29):e330. PubMed ID: 25546681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.
    Yang R; Zhang C; Malik A; Shen ZD; Hu J; Wu YH
    World J Gastroenterol; 2014 Nov; 20(44):16765-73. PubMed ID: 25469049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk.
    Long XD; Ma Y; Zhou YF; Yao JG; Ban FZ; Huang YZ; Huang BC
    BMC Cancer; 2009 Nov; 9():400. PubMed ID: 19919686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of xeroderma pigmentosum gene D Ls751Gln polymorphism and susceptibility to hepatocellular carcinoma.
    Wang Y; Zhao Y; Zhang A; Ma J; Wang Z; Zhang X
    Int J Clin Exp Pathol; 2015; 8(10):12949-54. PubMed ID: 26722489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of excision repair gene XPD Lys751Gln and hOGG1 Ser326Cys might not be associated with hepatocellular carcinoma risk: a meta-analysis.
    Zhang RC; Mou SH
    Tumour Biol; 2013 Apr; 34(2):901-7. PubMed ID: 23271362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in XPD (Asp312Asn and Lys751Gln) genes, sunburn and arsenic-related skin lesions.
    McCarty KM; Smith TJ; Zhou W; Gonzalez E; Quamruzzaman Q; Rahman M; Mahiuddin G; Ryan L; Su L; Christiani DC
    Carcinogenesis; 2007 Aug; 28(8):1697-702. PubMed ID: 17470448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the relationship between hepatocellular carcinoma and the interaction between polymorphisms in DNA repair gene XPD and environmental factors].
    Zeng XY; Qiu XQ; Ji L; Yu HP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jul; 30(7):702-5. PubMed ID: 19957595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA repair genes XPD and XRCC1 polymorphisms and risk of end-stage renal disease in Egyptian population.
    Radwan WM; Elbarbary HS; Alsheikh NM
    Ren Fail; 2015 Feb; 37(1):122-8. PubMed ID: 25310768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XPD Polymorphisms and Risk of Hepatocellular Carcinoma and Gastric Cancer: A Meta-Analysis.
    Zhou Q; Fu Y; Wen L; Deng Y; Chen J; Liu K
    Technol Cancer Res Treat; 2021; 20():1533033821990046. PubMed ID: 33517857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DNA repair gene xeroderma pigmentosum group D 751 polymorphism and the risk on esophageal cancer: a meta-analysis].
    Wu XB; Dai LP; Wang YP; Wang KJ; Zhang JY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Mar; 30(3):281-5. PubMed ID: 19642387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XPD Lys
    Yang QI; Wei YF; Zhang Y; Huang GM
    Exp Ther Med; 2015 Jun; 9(6):2406-2414. PubMed ID: 26136996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of polymorphisms in DNA repair genes with an increased risk of hepatocellular carcinoma.
    Wu JS; Chen YP; Wang LC; Yang YJ; Deng CW; Hou BX; He ZL; Chen JX
    Genet Mol Res; 2014 May; 13(2):3812-8. PubMed ID: 24938468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of XPD and XRCC1 genetic polymorphisms with hepatocellular carcinoma risk.
    Guo LY; Jin XP; Niu W; Li XF; Liu BH; Wang YL
    Asian Pac J Cancer Prev; 2012; 13(9):4423-6. PubMed ID: 23167354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA repair gene XPD polymorphisms and cancer risk: a meta-analysis based on 56 case-control studies.
    Wang F; Chang D; Hu FL; Sui H; Han B; Li DD; Zhao YS
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):507-17. PubMed ID: 18349268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies.
    Yin QH; Liu C; Hu JB; Meng RR; Li L; Wang YJ
    Asian Pac J Cancer Prev; 2013; 14(1):231-6. PubMed ID: 23534729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of polymorphisms in DNA repair genes in prognosis of hepatocellular carcinoma.
    Yue AM; Xie ZB; Guo SP; Wei QD; Yang XW
    Asian Pac J Cancer Prev; 2013; 14(1):355-8. PubMed ID: 23534753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
    Wang XC; Wang F; Quan QQ
    Genet Test Mol Biomarkers; 2016 Apr; 20(4):176-84. PubMed ID: 26918371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden.
    Ye W; Kumar R; Bacova G; Lagergren J; Hemminki K; Nyrén O
    Carcinogenesis; 2006 Sep; 27(9):1835-41. PubMed ID: 16571649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between polymorphisms of BAG-1 and XPD and chemotherapy sensitivity in advanced non-small-cell lung cancer patients treated with vinorelbine combined cisplatin regimen.
    Li P; Wang YD; Cheng J; Chen JC; Ha MW
    Tumour Biol; 2015 Dec; 36(12):9465-73. PubMed ID: 26124006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.